Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pedersen-Bjergaard

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Leukemia|July 3, 2002
Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8M K Andersen, J Pedersen-Bjergaard, L Kjeldsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literatureL Hoffmann, P Möller, J Pedersen-Bjergaard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
High activity of mitoxantrone in previously untreated low-grade lymphomasS W Hansen, N I Nissen, M M Hansen, et al.
Blood|December 1, 1985
Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lungJ Pedersen-Bjergaard, K Osterlind, M Hansen, et al.
Lancet (London, England)|February 24, 2001
Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapyM Gundestrup, M Klarskov Andersen, E Sveinbjornsdottir, et al.
Leukemia Research|December 24, 1997
The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemiaP de Nully Brown, J Jurlander, J Pedersen-Bjergaard, et al.
Lancet (London, England)|August 10, 1991
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursJ Pedersen-Bjergaard, G Daugaard, S W Hansen, et al.
British Journal of Haematology|September 13, 2001
Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992M K Andersen, D H Christiansen, B A Jensen, et al.
Blood|April 1, 1981
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typingJ Pedersen-Bjergaard, P Philip, B T Mortensen, et al.
British Journal of Haematology|October 1, 1980
Abolished production of interferon by leucocytes of patients with the acquired cytogenetic abnormalities 5q -- or -- 5 in secondary and de-novo acute non-lymphocytic leukaemiaJ Pedersen-Bjergaard, S Haahr, P Philip, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|July 3, 2002
Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8M K Andersen, J Pedersen-Bjergaard, L Kjeldsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literatureL Hoffmann, P Möller, J Pedersen-Bjergaard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
High activity of mitoxantrone in previously untreated low-grade lymphomasS W Hansen, N I Nissen, M M Hansen, et al.
Blood|December 1, 1985
Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lungJ Pedersen-Bjergaard, K Osterlind, M Hansen, et al.
Lancet (London, England)|February 24, 2001
Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapyM Gundestrup, M Klarskov Andersen, E Sveinbjornsdottir, et al.
Leukemia Research|December 24, 1997
The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemiaP de Nully Brown, J Jurlander, J Pedersen-Bjergaard, et al.
Lancet (London, England)|August 10, 1991
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursJ Pedersen-Bjergaard, G Daugaard, S W Hansen, et al.
British Journal of Haematology|September 13, 2001
Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992M K Andersen, D H Christiansen, B A Jensen, et al.
Blood|April 1, 1981
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typingJ Pedersen-Bjergaard, P Philip, B T Mortensen, et al.
British Journal of Haematology|October 1, 1980
Abolished production of interferon by leucocytes of patients with the acquired cytogenetic abnormalities 5q -- or -- 5 in secondary and de-novo acute non-lymphocytic leukaemiaJ Pedersen-Bjergaard, S Haahr, P Philip, et al.
Pageof 10